ALITAIR PHARMACEUTICALS
Alitair is a specialty pharmaceutical company with a focus on respiratory space. Currently, Alitair are developing two orphan drugs for bronchiectasis. They expect to begin phase II clinical trials for both compounds within the next 6 months. They also have products under development for prescription and over-the-counter cough treatment. Thirr lead cough candidate is a solid oral dosage form of benzonatate which is protected by a composition-of-matter patent. Currently, Alitair has four issued patents and we expect to expand our patent portfolio in the near future.
ALITAIR PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2010-01-01
Address:
Morristown, New Jersey, United States
Country:
United States
Website Url:
http://www.alitair.com
Total Employee:
1+
Status:
Active
Contact:
(973) 984-1669
Technology used in webpage:
ReCAPTCHA GStatic Google Static Content Squarespace Hosted
Similar Organizations
Celtrix Pharmaceuticals
Celtrix Pharmaceuticals is a pharmaceutical company that provides low-cost and generic prescription drugs.
Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.
Khepri Pharmaceuticals
Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics.
Current Employees Featured
